A detailed history of Farrow Financial Inc. transactions in Zoetis Inc. stock. As of the latest transaction made, Farrow Financial Inc. holds 11,570 shares of ZTS stock, worth $1.91 Million. This represents 1.42% of its overall portfolio holdings.

Number of Shares
11,570
Previous 11,528 0.36%
Holding current value
$1.91 Million
Previous $2 Billion 13.11%
% of portfolio
1.42%
Previous 1.36%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$172.58 - $196.48 $7,248 - $8,252
42 Added 0.36%
11,570 $2.26 Billion
Q2 2024

Jul 15, 2024

BUY
$145.54 - $178.83 $40,605 - $49,893
279 Added 2.48%
11,528 $2 Billion
Q1 2024

May 02, 2024

BUY
$165.67 - $199.94 $100,396 - $121,163
606 Added 5.69%
11,249 $1.9 Billion
Q4 2023

Feb 08, 2024

BUY
$151.44 - $200.09 $1.61 Million - $2.13 Million
10,643 New
10,643 $2.1 Billion

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $77.2B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Farrow Financial Inc. Portfolio

Follow Farrow Financial Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farrow Financial Inc., based on Form 13F filings with the SEC.

News

Stay updated on Farrow Financial Inc. with notifications on news.